Sweden

Sweden Information Region Europe Population 9182927 GDP (millions USD) 455319 National Policies Eggs for assisted reproduction commercial prohibited Eggs for research permitted Inheritable genetic modification PROHIBITED Preimplantation genetic diagnosis social uses prohibited Reproductive cloning PROHIBITED Research cloning regulated Sex selection Social uses prohibited Surrogacy PROHIBITED International Agreements 1997 COE Biomedicine Convention signed 1998 COE Cloning Convention signed 2005 UN Cloning Vote no 2005 UNESCO Sports Doping Convention RATIFIED 2007 Treaty of Lisbon signed

Key laws and policies

• Health and Medical Services Act No. 763/1982, which provides provisions on patients’ self-determination and on respect for the equal dignity of all human beings within health and medical services

• The Biobanks in Medical Care Act No. 297/2002 sets outs that biological material has to be collected, stored, and employed, taking into account the integrity of the person.

• Act on Ethics Review of Research Involving Humans, Law No. 460 (2003)

• Act concerning measures for the purposes of Research or Treatment in connection with Fertilized Human Oocytes, Law No. 115 of (March 14 1991, amended April 1, 2005)

• Genetic Integrity Act No. 351 of May 18, 2006 regulates assisted reproductive treatments.

Prohibited practices

Genetic Modification of Embryos

• Any research which seeks to genetically modify the embryo

Surrogacy

• Surrogacy is explicitly prohibited.

Commercial/For Profit

• Carrying out donations for profit is prohibited.

Permitted and regulated practices

Assisted Reproduction

• Chapter 6 of Act number 351/2006 establishes that “insemination may be carried out only if the woman is married or cohabiting. Written consent for insemination is required from the spouse or cohabitee.”

Pre-Implantation Genetic Diagnosis

• Genetic Integrity Act number 351/2006, Section 2 of Chapter 4 states, "Pre-implantation genetic diagnosis may only be used if the man or woman has a predisposition towards a serious monogenetic or chromosomal hereditary disease, which entails a high risk of having a child with a genetic disease or impairment. The treatment may not be used to choose characteristics, but only be aimed at preventing the child from inheriting the predisposition towards the disease or impairment in question.”
• To access to PGD, the authorization of the National Board of Health and Welfare is necessary.

Research Cloning

• Research cloning is permitted and regulated.

Egg Donation

• Providing eggs is allowed, both for reproduction and for research, but donation for profit is prohibited.